SciVision Biotech (TPE:1786) received approval from the Japan Patent Office for a new method of making auto-cross linked hyaluronic acid gel.
The patented process will boost product performance, broaden the company's offerings, and boost competitiveness.
The biotech company expects the development to have a positive impact on its business and shareholders, it added.